Hour24 News
Sophisticated and simple
-
Rewriting the Playbook for Open-Heart Surgery In a landmark medical achievement, surgeons have completed a coronary artery bypass without the patient’s chest being opened in…
-
Introduction Dapagliflozin, a leading SGLT2 inhibitor, has evolved from a glucose-lowering agent to a cornerstone therapy for heart failure (HF). Built on pivotal trials like…
